Baird Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,535
| Closed | -$1.17M | – | 1713 |
|
|
2023
Q2 | $1.17M | Buy |
13,535
+826
| +6% | +$71.6K | ﹤0.01% | 1069 |
|
|
2023
Q1 | $1.24M | Sell |
12,709
-13
| -0.1% | -$1.26K | ﹤0.01% | 1034 |
|
|
2022
Q4 | $1.32M | Sell |
12,722
-326
| -2% | -$33.7K | ﹤0.01% | 988 |
|
|
2022
Q3 | $1.11M | Sell |
13,048
-73
| -0.6% | -$6.19K | ﹤0.01% | 1013 |
|
|
2022
Q2 | $1.09M | Sell |
13,121
-4,368
| -25% | -$362K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $1.35M | Sell |
17,489
-701
| -4% | -$54.1K | ﹤0.01% | 1025 |
|
|
2021
Q4 | $1.61M | Sell |
18,190
-176
| -1% | -$15.5K | ﹤0.01% | 1019 |
|
|
2021
Q3 | $1.42M | Buy |
18,366
+64
| +0.3% | +$4.95K | ﹤0.01% | 1068 |
|
|
2021
Q2 | $1.53M | Sell |
18,302
-267,677
| -94% | -$22.3M | ﹤0.01% | 1020 |
|
|
2021
Q1 | $21.6M | Sell |
285,979
-4,022
| -1% | -$304K | 0.06% | 280 |
|
|
2020
Q4 | $25.4M | Buy |
290,001
+3,892
| +1% | +$341K | 0.08% | 247 |
|
|
2020
Q3 | $21.8M | Buy |
286,109
+283,742
| +11,987% | +$21.6M | 0.07% | 253 |
|
|
2020
Q2 | $292K | Sell |
2,367
-54
| -2% | -$6.66K | ﹤0.01% | 1308 |
|
|
2020
Q1 | $204K | Sell |
2,421
-865
| -26% | -$72.9K | ﹤0.01% | 1329 |
|
|
2019
Q4 | $278K | Sell |
3,286
-31,407
| -91% | -$2.66M | ﹤0.01% | 1350 |
|
|
2019
Q3 | $2.34M | Sell |
34,693
-16,509
| -32% | -$1.11M | 0.01% | 730 |
|
|
2019
Q2 | $4.39M | Sell |
51,202
-5,601
| -10% | -$480K | 0.02% | 548 |
|
|
2019
Q1 | $5.05M | Buy |
56,803
+1,748
| +3% | +$155K | 0.03% | 444 |
|
|
2018
Q4 | $4.69M | Buy |
55,055
+6,133
| +13% | +$522K | 0.03% | 432 |
|
|
2018
Q3 | $4.83M | Sell |
48,922
-1,439
| -3% | -$142K | 0.03% | 453 |
|
|
2018
Q2 | $4.74M | Buy |
50,361
+4,762
| +10% | +$449K | 0.03% | 446 |
|
|
2018
Q1 | $3.7M | Sell |
45,599
-3,265
| -7% | -$265K | 0.03% | 481 |
|
|
2017
Q4 | $4.36M | Sell |
48,864
-10,987
| -18% | -$980K | 0.03% | 446 |
|
|
2017
Q3 | $5.57M | Sell |
59,851
-108
| -0.2% | -$10.1K | 0.04% | 396 |
|
|
2017
Q2 | $5.45M | Buy |
59,959
+709
| +1% | +$64.4K | 0.04% | 388 |
|
|
2017
Q1 | $5.2M | Buy |
59,250
+6,920
| +13% | +$607K | 0.04% | 391 |
|
|
2016
Q4 | $4.34M | Buy |
52,330
+9,209
| +21% | +$763K | 0.04% | 397 |
|
|
2016
Q3 | $3.99M | Buy |
43,121
+33,783
| +362% | +$3.13M | 0.04% | 415 |
|
|
2016
Q2 | $826K | Buy |
+9,338
| New | +$826K | 0.01% | 793 |
|